• DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic Preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi - Best Science for the Most Neglected 20 Years
  • DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic Preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Press releases

Global COVID-19 research agenda still missing the priorities of low- and middle-income countries

An article published today in The Lancet calls for urgent collaboration and coordination for unmet, underfunded COVID-19 research priorities in low-resource settings

Home > Press releases

Global COVID-19 research agenda still missing the priorities of low- and middle-income countries

An article published today in The Lancet calls for urgent collaboration and coordination for unmet, underfunded COVID-19 research priorities in low-resource settings

Healthcare worker conducts COVID-19 test in South Africa
7 May 2021
Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

Over a year into the COVID-19 pandemic, coordination of an inclusive global research response remains limited. While there has been important leadership in COVID-19 research in many low- and middle-income countries (LMICs), most COVID-19 research globally focuses on the issues of greatest importance in high-income countries.

An article published today in The Lancet, ‘COVID-19 research response and preparedness in low-resource settings: urgent priorities’, outlines what is needed for a more effective and truly global research response to the pandemic.

The article summarizes the conclusions of researchers and funders in a recent virtual meeting, ‘COVID-19 Research in Low- and Middle-income Countries’. The authors highlight barriers to funding and implementing research in low-resource settings during the pandemic, and the need for greater domestic and international mobilization of resources and research coordination.

Critical research gaps remain, including:

  • Clinical research on affordable, available, deployable tools to diagnose, treat and prevent COVID-19 in low-resource settings,
  • Assessment of direct and indirect impacts of COVID-19 on public health and health systems,
  • Strengthening of disease surveillance, biobanking and sequencing capacity, and
  • Interdisciplinary research that takes a “One Health” approach.

The authors propose a framework that links these areas with private sector R&D and additional cross-cutting issues such as community-centred approaches, data sharing, and rapid funding mechanisms, as well as pandemic prediction capacities.

The ‘COVID-19 Research in Low- and Middle-income Countries’ meeting was organised in late March 2021 by the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), the UK Collaborative on Development Research (UKCDR), and the COVID-19 Clinical Research Coalition, bringing together global research funders, including those who are funding research on COVID-19 in LMICs, with researchers who are actively undertaking this research in LMICs. 

‘GloPID-R is excited to move this agenda forward through its LMIC funder working group and through an ongoing drive to expand regional membership and improve collaboration and cohesion of research funding preparedness and response,’ said Prof. Charles Wiysonge, GloPID-R Vice Chair, South Africa.

‘Through our COVID-19 research mapping and analysis work we see that investment in COVID-19 research has slowed,’ said Dr Alice Norton, Head of COVID CIRCLE at UKCDR, and corresponding author. ‘This means we must now focus our efforts on the outstanding gaps in research efforts which remain in low-resource settings. This requires supporting regionally identified priorities through listening to the voices of local researchers.‘

‘UKCDR will take this agenda forward through its Epidemics Preparedness and Response Group and Strategic Coherence for ODA Research (SCOR) Board to inform decision making and ensure strategic coherence,’ said Dr Marta Tufet, Executive Director, UKCDR.

‘Scientists and clinicians in low- and middle-income countries have had too little influence on global research priority-setting during the pandemic and too little support,’ said Prof. Helen Rees, a Steering Committee member of the COVID-19 Clinical Research Coalition, South Africa. ‘We need to change this for many excellent reasons – most importantly, an end to this pandemic and the beginning of genuinely global health informed by sustained biomedical research excellence in all countries.‘

‘Ending this pandemic will require genuinely global collaboration and a streamlined approach to research prioritization and funding,’ said Prof. Nick White, Steering Committee chair for the COVID-19 Clinical Research Coalition. ‘We need targeted, high-quality research led by scientists and clinicians in low-resource settings to answer urgent questions of relevance in those settings.’

Read The Lancet Commentary ‘Priorities for COVID-19 research response and preparedness in low-resource settings’

About GloPID-R

The Global Research Collaboration for Infectious Disease Preparedness is an international alliance of 29 funding organizations and 3 observers (WHO, CEPI, EDCTP).  GloPID-R facilitates coordinated research related to new and emerging infectious diseases with epidemic and pandemic potential by supporting research preparedness and rapid response to outbreaks, promoting collaboration and coordination among funders based on common goals and principles, and identifying gaps to align funding with research needs, especially in LMICs.

 www.glopid-r.org

About UKCDR

The UK Collaborative on Development Research (UKCDR) is a group of UK government departments and research funders working in international development research.

UKCDR exists to amplify the value and impact of research for global development by promoting coherence, collaboration and joint action among UK research funders. UKCDR is governed by the Strategic Coherence of ODA-funded Research (SCOR) Board.

ukcdr.org.uk

About COVID CIRCLE

UKCDR and GloPID-R partnered in 2020 to establish the COVID-19 Research Coordination and Learning Initiative (COVID CIRCLE) to align and strengthen the research response in, with and for LMICs.

ukcdr.org.uk/covid-circle/

About the COVID-19 Clinical Research Coalition

The COVID-19 Clinical Research Coalition brings together individuals and institutions working to accelerate COVID-19 research that will provide evidence on COVID-19 prevention, diagnosis, and case management in resource-limited settings. The coalition was created by DNDi, the Mahidol-Oxford Tropical Medicine Research Unit, and the Infectious Diseases Data Observatory (IDDO). DNDi hosts the coalition’s secretariat.

A not-for-profit research and development organization, DNDi works to deliver new treatments for neglected patients, those living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, and hepatitis C. DNDi is also coordinating the ANTICOV clinical trial to find treatments for mild-to-moderate COVID-19 cases in Africa. DNDi hosts the secretariat of the COVID-19 Clinical Research Coalition.

Media contacts

UKCDR
Nicole Huxley (UK)
n.huxley@ukcdr.org.uk 
+44 (0)20 7611 2093

DNDi
Frédéric Ojardias (Switzerland)
fojardias@dndi.org 
+41 79 431 62 16 

GloPID-R
Mary Shaffer (France)
mary.shaffer@ext.fondation-merieux.org

Photo credit: Xavier Vahed-DNDi

Partnership Pandemic Preparedness

Read, watch, share

Loading...
Centre of Excellence in India
News
14 Sep 2023

DNDi’s Centres of Excellence: Towards the sustainable elimination of visceral leishmaniasis in India

Delali Attip
Press releases
6 Sep 2023

Biotech leader Delali Attiogbe Attipoe joins DNDi as North America Director

Viewpoints
5 Sep 2023

Africa should bolster research into climate-sensitive diseases

Context
Prof. Sam Kariuki, DNDi Eastern Africa Director and Leonard Ithau, Rotary International District 9212 District Governor shaking hands
News
29 Aug 2023

DNDi and Rotary collaborate to prevent and treat diseases affecting neglected communities in Eastern Africa

Mother and child in a hospital
Viewpoints
24 Aug 2023

A drug development model for the diseases the world forgot

Africa Arguments
Statements
21 Aug 2023

DNDi urges G20 to operationalize equity in response to major global health challenges and priorities

Man looking into a microscope
Press releases
31 Jul 2023

Certara and DNDi partnering to fast-track data submissions and accelerate drug approvals for neglected patients

DNDi Prof. Fahal Interview 2023 Cover Image
Videos
25 Jul 2023

Prof. Fahal On The 20 Years of Innovating Together In Helping Mycetoma Patients

VIEW ALL

Help neglected patients

To date, we have delivered twelve new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
DNDi - Best Science for the Most Neglected 20 Years
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
This website uses necessary cookies to function. If you give your consent, we will also use statistical, functional, and marketing cookies. See Cookie Policy.
Customize
REJECT ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo